He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...
Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.
A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...